Enzene Biosciences has raised $ 50 million to improve its manufacturing capability in order to provide affordable, high-quality medicines that save lives. ... Jan 31
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
Top ten pharma stocks January 2021... Jan 06
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan® (rituximab)... Dec 18
Tanzania will be the first country in Africa that will benefit from this collaboration between Biocon Biologics and CSSC.... Dec 17
Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ... Dec 10
Tuznue is a mAb biosimilar to Roche’s Herceptin (trastuzumab)... Nov 13
Novartis and Molecular Partners AG today announced a collaboration to develop two DARPin® therapies designed for potential use against COVID-19... Oct 28
IAVI and Scripps Research as innovative interventions to address the COVID-19 pandemic.... Oct 23
This eye allergy drop indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander... Sep 17
Brink Bilogics licenses bioanalytical testing solution to Fresenius Kabi SwissBioSim GmbH... Sep 11
Major breakthrough for treatment of Nasopharyngeal Carcinomar ... Sep 11
Biocon Biologics and Mylan announce launch of Semglee (insulin glargine injection) in the U.S. to expand access for patients living with diabetes ... Aug 31
The approval of Nepexto by the European Medicines Agency (EMA) underlines the scientific success of Lupin’s biosimilar programs... Aug 26
Favipiravir licensed from Fujifilm by Dr Reddy's ... Aug 20
Aurobindo Pharma Hyderabad is ready for impressive growth, riding on vaccines and Biosimilars for Covid-19... Aug 10
... Aug 06
The vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies, it also able to elicit high level of ... Aug 05
Hetero announces today the launch of generic Favipiravir in India under the brand name ‘Favivir... Jul 29
Medicines will be sold at zero-profit to governments in up to 791 eligible countries during the pandemic and until a vaccine or curative treatment ... Jul 17
FDA ODD status for PBP1510 the new molecule for treating pancreatic cancer... Jun 30
Hetero launches Remdesivir generic named Covifor for Indian markets ... Jun 23
NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia... Jun 17
Semglee is to be offered in vial and pen presentations... Jun 12
Biocon Biologics receives EU GMP certification for multiple biosimilars manufacturing facilities in Bengaluru ... May 27
-Advertisements-